Impact of Osteoporotic Fractures on Work: Data From a Fracture Liaisons Service
OPTIWORK
1 other identifier
observational
121
1 country
1
Brief Summary
Osteoporosis is a bone disease characterized by a decrease in bone density with deterioration of the micro-architecture and the appearance of bone fragility, responsible for an increased risk of fractures. The most common osteoporotic fractures are spinal, wrist and femoral neck fractures. Osteoporosis affects 22.7% of women and 6.9% of men in France. Each year, around 8.9 million fragility fractures are identified worldwide, with an incidence in France in 2017 of 382,000 patients in France in 2017. The economic impact, the functional consequences and the quality of life of patients with osteoporosis, fracture or not, have been widely described in the literature in recent years. There is indeed a great alteration in the mobility, functional capacities and overall quality of life of these patients, measured by composite scores such as Short Form-36 (SF-36), EuroQol 5 Dimensions (EQ-5D) , the Health-related quality of life (HRQoL), or more specifically for osteoporosis, osteoporososis quality of life questionnaire (OQLQ) or its shortened version OLQ, the osteoporosis assessment questionnaire (OPAQ), the Quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO) (specific for vertebral fractures), etc. However, few studies have focused on the repercussions of osteoporotic fractures at work, because this pathology affects more elderly subjects (\> 65 years old) and therefore retirees.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2020
CompletedFirst Submitted
Initial submission to the registry
March 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedMarch 9, 2021
March 1, 2021
3 months
March 1, 2021
March 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the consequences of osteoporotic fractures on the rate of return to work at 3 months of active patients under 65 years of age
Rate of patients returning to work 3 months after fracture
Month 3
Secondary Outcomes (3)
To assess the consequences of osteoporotic fractures on the average return to work time of active patients under 65 years of age.
Day 1
Evaluate the consequences of osteoporotic fractures on quality of life in active patients under 65
Month 3
Define the predictive factors for not returning to work.
Day 1
Interventions
All patients treated between 01/01/2017 and 12/31/2018 in the Fracture sector will be screened through the computerized medical file. For patients who meet all the eligibility criteria, the information note, study questionnaire and a stamped envelope will be sent to them by post. Without feedback from him within 30 days of this submission, the patient is considered not to have objected to the study. The patient's information as well as his non-objection will be recorded in his medical file.
Eligibility Criteria
All patients treated between 01/01/2017 and 31/12/2018 in the Fracture sector will be screened through the computerized medical file
You may qualify if:
- Patients aged 18 to 65 at the time of the fracture
- French-speaking patient
- Patients treated in the Fracture Line between January 1, 2017 and December 31, 2018 for osteoporotic fracture
- Professionally active patients at the time of the fracture
You may not qualify if:
- Refusal to participate in the study
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint-Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnès PORTIER
Fondation Hôpital Saint-Joseph
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2021
First Posted
March 4, 2021
Study Start
April 26, 2019
Primary Completion
July 15, 2019
Study Completion
September 21, 2020
Last Updated
March 9, 2021
Record last verified: 2021-03